Disease: MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA ×
Source: ALL
Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA
CUI: C1851585
Disease: MYELOPROLIFERATIVE DISORDER, CHRONIC, WITH EOSINOPHILIA
0.010 GeneticVariation BEFREE In conclusion bevacizumab plus EGFR-TKIs could be a valuable treatment for NSCLC patients presenting with MPE upon resistant to EGFR-TKIs therapy, especially for those with acquired T790M mutation. 28977977 2017